Lv51
1268 积分 2022-08-03 加入
CoREST complex inhibition alters RNA splicing to promote neoantigen expression and enhance tumor immunity
6天前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
19天前
已完结
444 TNG260, a CoREST-selective deacetylase inhibitor, reverses anti-PD1 resistance driven by loss of STK11
20天前
已关闭
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
23天前
已完结
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
23天前
已完结
<p>TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP), A Novel Therapeutic Target Of Breast Cancer</p>
23天前
已完结
PARP7 Inhibition: A Promising Pathway to Advancements in Cancer Therapy
1个月前
已完结
Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment
1个月前
已完结
Abstract 4369: Preclinical characterization of a dual-state pan-KRAS Inhibitor
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
皖公网安备34019202002308
